Third generation EGFR TKIs: current data and future directions

Acquired T790 M mutation is the commonest cause of resistance for advanced non-small cell lung cancer (NSCLC) epidermal growth factor receptor (EGFR) mutant patients who had progressed after first line EGFR TKI (tyrosine kinase inhibitor). Several third generation EGFR TKIs which are EGFR mutant sel...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Chee-Seng, Kumarakulasinghe, Nesaretnam Barr, Huang, Yi-Qing, Ang, Yvonne Li En, Choo, Joan Rou-En, Goh, Boon-Cher, Soo, Ross A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817792/
https://www.ncbi.nlm.nih.gov/pubmed/29455654
http://dx.doi.org/10.1186/s12943-018-0778-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5817792/
https://www.ncbi.nlm.nih.gov/pubmed/29455654
http://dx.doi.org/10.1186/s12943-018-0778-0

Ejemplares similares